Dr. Xue Bai is an Associate Researcher and Attending Physician in Radiation Oncology at Nanfang Hospital, Southern Medical University. She earned her Ph.D. from Peking Union Medical College in 2016 and finished postdoctoral research at Nanfang Hospital. Her research targets the tumor microenvironment, vascular remodeling, and immunotherapy resistance in LKB1-mutant lung cancer. As Principal Investigator, she leads three NSFC projects on CD73-adenosine, ATM-mediated pericytes, and SMARCA4-deletion mechanisms, alongside multiple provincial grants. She published breakthrough first/corresponding author papers in Cancer Cell (IF: 48.8), Nature Communications, JITC, Cancer Research, and Cell Reports Medicine. She holds four Chinese and one international patent for tumor subtyping, high endothelial venule quantification, and immunotherapy prediction. Dr. Bai presented orally at WCLC 2020 and 2023. Accolades include the WCLC Early Career Education Award, CSCO "35 Under 35", and Guangdong "Young Top Talent". She is Secretary of the Radiation Therapy Management Youth Committee (Guangdong Hospital Association). Her university teaching awards reflect her broad impact.
Southern Medical University
Guangzhou, Guangdong, China
Department of Radiation Oncology
Young Top Talent, 9th Guangdong Special Support Program
Guangdong Province
Selected in 2025 for the prestigious provincial talent program supporting exceptional young researchers.
Outstanding Youth Cultivation Plan
Nanfang Hospital, Southern Medical University
Selected in November 2020 for the hospital's distinguished program cultivating promising young medical professionals.
Provincial Third Prize, Curriculum Ideology and Politics Case
Guangdong Province
Awarded in 2023 for excellence in medical teaching case design under the "New Medical Science" perspective
First Prize (English Group), Undergraduate Course Teaching Competition
Southern Medical University
Won the university-level First Prize for outstanding English-language undergraduate teaching design in 2021.
CSCO 35 Under 35 National Outstanding Young Oncologist
Chinese Society of Clinical Oncology (CSCO)
Recognized in 2024 as one of the top outstanding young oncologists in China
Early Career Education Award
World Conference on Lung Cancer (WCLC)
Awarded at the WCLC 2020 for outstanding early-career research and contributions to the field of lung cancer.
Senior Scientist or Principal Investigator
Nanfang Hospital, Southern Medical University, Guangzhou, China
01 Aug 2024 - present
University Educator/Researcher
Nanfang Hospital, Southern Medical University, Guangzhou, China
01 Oct 2020 - present
Post Doctoral Researcher
Nanfang Hospital, Southern Medical University, Guangzhou, China
01 Oct 2018 - 01 Sep 2020
Resident Physician (Oncology)
The first affiliated hospital of Xinjiang Medical University, Ürümqi, China
01 Aug 2016 - 01 Aug 2018